Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone Formation. - Wikidata - awgldk - TriplyDB

Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone Formation.

Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone Formation.

http://www.wikidata.org/entity/Q37040159

about

Neural EGF-like protein 1 (NELL-1): Signaling crosstalk in mesenchymal stem cells and applications in regenerative medicine.The Effects of Systemic Therapy of PEGylated NELL-1 on Fracture Healing in Mice.

P2860

Q47141932-A5DF1B6E-DC17-42BD-8B5B-62A8ACA80316 Q47205012-DB6FACD4-21A9-4FFE-BB8F-E4E7215B3A55

P2860

Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone Formation.

http://www.wikidata.org/entity/Q37040159

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone Formation.

@en

Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone Formation.

@nl

type

label

Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone Formation.

@en

Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone Formation.

@nl

prefLabel

Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone Formation.

@en

Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone Formation.

@nl

P1433

Q37040159-F839527D-3D98-4D28-A96A-6FBE41DA0931

P1476

Q37040159-A29A786F-0CC5-4224-9E9A-F32DFBE8501A

P2093

Q37040159-0761688A-5470-4278-8904-0FB0C9535B88

Q37040159-1C43D67D-CE97-4144-9785-CB8D6CF42601

Q37040159-2929F047-3F2B-43A6-9C9B-6BD7C7C23FB0

Q37040159-46D48752-2ADA-42B8-84EF-61147CFE1BB3

Q37040159-545A5474-4502-4A09-8279-BC1A7419D5B8

Q37040159-877F2979-4B9F-4859-AB3A-364ECD597081

Q37040159-9121107D-5CDD-47F1-A459-4302528F45C5

Q37040159-9A053D5E-9CC1-4B6D-880B-A4F400F13CE3

Q37040159-C04D9A8D-0BED-4497-965E-65F91F43D43C

Q37040159-C379004A-3D2F-42BC-B266-3720079C845D

P2860

Q37040159-058285CB-8174-43F6-908B-25BEE5DAB85C

Q37040159-07F4F2B1-FF20-4462-ADBC-E93121E7E7F4

Q37040159-12BE8B25-6DD8-4549-8EDD-2F647C0C22FD

Q37040159-14F38692-C76F-42FD-AF75-A25C7CC3B4FB

Q37040159-152179C7-B542-4513-9A7F-1E3F3D47499D

Q37040159-16C719C7-68FC-4D98-BECB-79B3B9C2D28F

Q37040159-19A95493-9F08-40C7-A633-DCF8AE76B356

Q37040159-19DE3A3A-9042-49F9-806D-5ACF021BB0DF

Q37040159-1C6F1576-BDB8-4D0B-B70C-9B87DB415EDF

Q37040159-23A0DA27-E140-45E5-9CB1-046C78A06E07

P304

Q37040159-B080AEC2-A5B7-4106-B084-65B6957CB36D

P31

Q37040159-8C81DF01-DD60-452C-86B5-74471A508F39

P356

Q37040159-423684D4-AFCA-4801-997A-A97A24F4C065

P433

Q37040159-F465F31C-4232-4E60-8840-2B518266EE56

P478

Q37040159-4502CEDD-1E54-40C4-B481-E9156813F782

P50

Q37040159-B03611E6-A7D2-4873-9E3F-42E0272F3804

P577

Q37040159-A4DBF709-A124-48F7-BC90-B3EF340DA01F

P698

Q37040159-B34E5620-5C42-4986-8647-8C76300ABDDF

P932

Q37040159-9E088B3B-5F6E-4EFA-852A-F438A0AD3F70

P356

BIORES.2016.0018

P1433

BioResearch open access

P1476

Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone Formation.

@en

P2093

Benjamin Wu

http://www.w3.org/2001/XMLSchema#string

Chia Soo

http://www.w3.org/2001/XMLSchema#string

Eric Chen

http://www.w3.org/2001/XMLSchema#string

Jin Hee Kwak

http://www.w3.org/2001/XMLSchema#string

Justine Tanjaya

http://www.w3.org/2001/XMLSchema#string

Kang Ting

http://www.w3.org/2001/XMLSchema#string

Pia Ang

http://www.w3.org/2001/XMLSchema#string

Soonchul Lee

http://www.w3.org/2001/XMLSchema#string

Sotirios Tetradis

http://www.w3.org/2001/XMLSchema#string

Xinli Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide pleiotropy of osteoporosis-related phenotypes: the Framingham Study

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

Comparative pharmacokinetics of cefuroxime lysine after single intravenous, intraperitoneal, and intramuscular administration to rats.

Bioactivity and circulation time of PEGylated NELL-1 in mice and the potential for osteoporosis therapy

Human NELL-1 expressed in unilateral coronal synostosis.

Craniosynostosis-associated gene nell-1 is regulated by runx2.

Nell-1 protein promotes bone formation in a sheep spinal fusion model.

The use of 18F-fluoride and 18F-FDG PET scans to assess fracture healing in a rat femur model

Effect of pegylation on pharmaceuticals.

Effect of odanacatib on BMD and fractures: estimates from Bayesian univariate and bivariate meta-analyses.

P304

159-170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/BIORES.2016.0018

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27354930

http://www.w3.org/2001/XMLSchema#string

P932

4921932

http://www.w3.org/2001/XMLSchema#string